LMND Earnings

Lemonade Announces Second Quarter 2025 Financial Results

Published August 05, 2025 at 10:00 AM

NEW YORK--(BUSINESS WIRE)--Lemonade, Inc. (NYSE: LMND) has released its second quarter 2025 financial results by posting them to its website. You may view the financial results in the Q2 2025 Letter to Shareholders. Today, Lemonade will host a conference call at 8:00 am Eastern time (5:00 am Pacific time) to discuss the results. To join the call, please dial in, toll-free at (833) 470-1428, or at (404) 975-4839; conference ID: 820365. To join the live webcast please visit the Lemonade Investor

Related Questions

What guidance did management provide for Q3 2025 and full‑year 2025 earnings, revenue, and cash flow? How did underwriting profit and expense ratio trend and what impact does that have on profitability outlook? How does Lemonade’s Q2 performance compare to its main competitors (e.g., Hippo, Root, or traditional insurers) in terms of growth and profitability? What is the stock’s expected reaction to the earnings release and guidance—will we see volatility or a sustained trend? What is the outlook for claim frequency and severity in the next quarters, and how might that affect the loss ratio? Did the company's balance sheet show any significant changes in cash, debt, or liquidity that could affect capital allocation? Are there any changes to the company's AI or automation initiatives that could improve operational efficiency or risk assessment? What was the change in gross profit margin and loss ratio versus the prior quarter and year‑over‑year? What is the expected impact of the Q2 results on the company’s growth trajectory and long‑term strategic plan? What is the current churn rate and customer acquisition cost, and are there any trends in policy growth or retention? Did management address any guidance on capital raise, share buybacks, or dividend policy? What new products, markets, or partnerships were announced, and how might they affect future revenue streams? What was the impact of any recent regulatory changes or insurance‑industry trends on Lemonade’s underwriting performance? How did Lemonade's Q2 2025 revenue and earnings compare to consensus analyst estimates? How might the Q2 results and guidance affect the stock’s valuation multiples (P/E, P/Revenue) and target price?